MedPath

Evaluation of diagnostic subsystem for neurodevelopmental disorders (ASD, ADHD) using wearable NIRS.

Not Applicable
Conditions
Autism spectrum disorder, Attention-deficit/hyperactivity disorders
Registration Number
JPRN-UMIN000029200
Lead Sponsor
SHIONOGI &CO., LTD
Brief Summary

We performed the planned experiment using NIRS on 13 TDs and 16 ASD/ADHD participants. Although it was difficult to segregate ASD/ADHD from TD as total paraticipant's group, we obtained approximately 70% diagnostic accuracy using three combined parameters when participants were divided in two groups according to their age.

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Developmental disorders: Those who takes ADHD remedy. Typically developed: Those who are suspected as developmental disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We measure oxy-Hb, deoxy-Hb, and total-Hb, using wearable NIRS, and the data will be processed to evaluate the activation-deactivation pattern of the prefrontal cortex. Also we will ask the participants to fill out the questionnaire to confirm the psychological status of their disorders. Collected data will be analyzed within 6 months from the measurement.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath